HSBC raised its price target to $315, and the FDA issued a complete response letter regarding trenibotE.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
HSBC raised its price target to $315, and the FDA issued a complete response letter regarding trenibotE.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- HSBC provided a buy rating and price target for Johnson & Johnson, while Morgan Stanley raised its price objective to $294.00. The company also filed required 13F reports with the SEC.
- Bank of America decreased its price target and set a buy rating, while HSBC assumed coverage and set a buy rating for MakeMyTrip.